FI60971C - Foerfarande foer foerbaettring av interferonutbyte - Google Patents

Foerfarande foer foerbaettring av interferonutbyte Download PDF

Info

Publication number
FI60971C
FI60971C FI782249A FI782249A FI60971C FI 60971 C FI60971 C FI 60971C FI 782249 A FI782249 A FI 782249A FI 782249 A FI782249 A FI 782249A FI 60971 C FI60971 C FI 60971C
Authority
FI
Finland
Prior art keywords
cells
interferon
cell
medium
concentration
Prior art date
Application number
FI782249A
Other languages
English (en)
Finnish (fi)
Other versions
FI60971B (fi
FI782249A7 (fi
Inventor
Michael Denis Johnston
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI782249A7 publication Critical patent/FI782249A7/fi
Publication of FI60971B publication Critical patent/FI60971B/fi
Application granted granted Critical
Publication of FI60971C publication Critical patent/FI60971C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
FI782249A 1977-07-15 1978-07-14 Foerfarande foer foerbaettring av interferonutbyte FI60971C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2987177 1977-07-15
GB2987177 1977-07-15

Publications (3)

Publication Number Publication Date
FI782249A7 FI782249A7 (fi) 1979-01-16
FI60971B FI60971B (fi) 1982-01-29
FI60971C true FI60971C (fi) 1982-05-10

Family

ID=10298554

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782249A FI60971C (fi) 1977-07-15 1978-07-14 Foerfarande foer foerbaettring av interferonutbyte

Country Status (15)

Country Link
US (1) US4216203A (cs)
EP (1) EP0000520B1 (cs)
JP (1) JPS5420119A (cs)
AT (1) AT362334B (cs)
AU (1) AU524099B2 (cs)
CA (1) CA1115209A (cs)
CS (1) CS215108B2 (cs)
DE (1) DE2860559D1 (cs)
DK (1) DK147625C (cs)
ES (1) ES471721A1 (cs)
FI (1) FI60971C (cs)
HU (1) HU179655B (cs)
IL (1) IL55143A0 (cs)
IT (1) IT1107573B (cs)
PL (1) PL110704B1 (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2961658D1 (en) * 1978-05-17 1982-02-18 Thomae Gmbh Dr K Process for preparing human interferon
JPS55122717A (en) * 1979-03-15 1980-09-20 Asai Gerumaniumu Kenkyusho:Kk Interferon inducer
DE2946275A1 (de) * 1979-11-16 1981-05-27 Dr. Karl Thomae Gmbh, 7950 Biberach Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
IE57069B1 (en) 1980-04-03 1992-04-22 Biogen Inc Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
JPS5754586A (en) * 1980-09-18 1982-04-01 Ajinomoto Co Inc Cell strain producing human interferon prolongably, its preparation, and preparation of human interferon using it
FR2502009A1 (fr) * 1981-03-23 1982-09-24 Centre Nat Rech Scient Perfectionnements aux procedes de fabrication d'interferon
EP0062085B1 (de) * 1981-04-07 1985-08-14 Dr. Karl Thomae GmbH Verbessertes Verfahren zur Herstellung von Humaninterferon aus lymphoblastoiden Zellen
HU184972B (en) * 1981-12-01 1984-11-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing human gamma interferone
FI832252A7 (fi) * 1982-06-21 1983-12-22 The Wellcome Foundation Ltd Parannettu menetelmä interferonin tuottamiseksi.
US4745053A (en) * 1983-07-08 1988-05-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyojo Process for producing human interferon and method for assaying the interferon productivity of blood
US6774283B1 (en) 1985-07-29 2004-08-10 Calgene Llc Molecular farming
US4956282A (en) * 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
DE3930140A1 (de) * 1989-09-09 1991-03-21 Bayer Ag Verfahren zur herstellung von biologischen materialien in zellkulturen und vorrichtungen
US5378612A (en) * 1990-05-11 1995-01-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Culture medium for production of recombinant protein
JPH0775593A (ja) * 1993-09-08 1995-03-20 Suntory Ltd 蛋白質の製造方法
CA2203377A1 (en) * 1995-08-30 1997-03-06 Akira Matsumori Method for testing myocarditis or cardiomyopathy
US6833271B2 (en) * 1996-12-04 2004-12-21 Medi-Cult A/S Serum-free cell culture media
SE513313C2 (sv) 1998-12-29 2000-08-21 Bionative Ab Modifierad interferonproduktion
US7294481B1 (en) 1999-01-05 2007-11-13 Immunex Corporation Method for producing recombinant proteins
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
JP7015917B2 (ja) 2018-05-31 2022-02-03 東芝キヤリア株式会社 タッチパネルを用いた設備管理装置および管理画面生成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2282910A2 (fr) 1974-08-26 1976-03-26 Anvar Procede de fabrication a l'echelle industrielle de preparations d'interferon de titre eleve
DE2461379A1 (de) * 1974-01-11 1975-07-17 Anvar Verfahren zur herstellung von interferon in grossen mengen und in industriellem masstab

Also Published As

Publication number Publication date
DK147625C (da) 1985-04-29
JPS5646797B2 (cs) 1981-11-05
EP0000520B1 (en) 1981-03-25
DE2860559D1 (en) 1981-04-16
FI60971B (fi) 1982-01-29
AU3804978A (en) 1980-01-17
IT7850322A0 (it) 1978-07-14
ATA510378A (de) 1980-10-15
US4216203A (en) 1980-08-05
IL55143A0 (en) 1978-09-29
JPS5420119A (en) 1979-02-15
ES471721A1 (es) 1979-02-01
EP0000520A1 (en) 1979-02-07
PL110704B1 (en) 1980-07-31
AT362334B (de) 1981-05-11
CA1115209A (en) 1981-12-29
DK147625B (da) 1984-10-22
CS215108B2 (en) 1982-07-30
FI782249A7 (fi) 1979-01-16
IT1107573B (it) 1985-11-25
PL208407A1 (pl) 1979-03-12
HU179655B (en) 1982-11-29
DK316978A (da) 1979-01-16
AU524099B2 (en) 1982-09-02

Similar Documents

Publication Publication Date Title
FI60971C (fi) Foerfarande foer foerbaettring av interferonutbyte
US4495282A (en) Process for producing target cell lysis factor and uses therewith
Horwitz et al. Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin
NL192086C (nl) Werkwijze ter bereiding van interferonen en werkwijze ter bereiding van een geneesmiddel dat interferonen bevat.
EP0053135B1 (en) Production of ifn-gamma
US4376821A (en) Production of human IFN-gamma (immune) interferon
IE863405L (en) Low dosage of interferon to enhance vaccine efficiency
CN101386840A (zh) Cd3-cd56+nk细胞高效扩增培养系统的构建方法
FI72143B (fi) Foerfarande foer framstaellning av maenniskointerferon
CS251766B2 (en) Method of interferon production
CN119161391A (zh) 一种Ru(II)配合物及其制备方法和应用
US4480032A (en) Natural mixture of Type I and Type II interferons
Maehara et al. Enhanced Production of Virus‐Inhibiting Factor (Interferon) in Human Diploid Cells by Ultraviolet Irradiation and Temperature Shift‐Down after Stimulation with Newcastle Disease Virus
CN101966335B (zh) 一种新的HER2/neu基因改造的树突细胞疫苗
CN114672458A (zh) 来源于肿瘤患者胸腹水的具有肿瘤特异性杀伤效果的t淋巴细胞及其制备方法和细胞制剂
JP2926409B2 (ja) 癌転移抑制因子の製造方法
JPS624117B2 (cs)
Lee Interferon production by human leukocytes in vitro: some biological characteristics
CN105199016A (zh) Deae-琼脂凝胶微球及其制备方法与应用
CN106480022B (zh) 干涉片段及其应用
Gazdar et al. Synthetic RNA and DNA polynucleotides: in vivo and in vitro enhancement of oncogenesis by a murine sarcoma virus
Husson et al. Investigations on antiviral action of Haemanthus albiflos natural extract
CN100494213C (zh) 一种生产人造血增效因子的制备方法及所用的核苷酸序列
SU1495374A1 (ru) Штамм культивируемых клеток животных MUS мUSсULUS - продуцент ростстимулирующих факторов гибридом
CN106480023B (zh) 干涉片段及其应用

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: THE WELLCOME FOUNDATION LIMITED